APOA5 and metabolic syndrome: Similarly, there was an indication of an increased risk of MetS among the subjects after adjustment of covariates for genetic models in the APOA5 rs662799 (P [additive model] = 0.0086; P [recessive model] = 0.0229; P [dominant model] = 0.0218), BUD13 rs11216129 (P [dominant model] = 0.0027), BUD13 rs623908 (P [dominant model] = 0.0027), and LIPA rs1412444 (P [additive model] = 0.0097; P [recessive model] = 0.0171) SNPs (Table 2).